Delphi Consensus Outlines Anti-TNF Introduction, Monitoring

Experts recommended the early use of anti-TNF therapy for patients with ulcerative colitis and Crohn disease, offering further input regarding the introduction, optimization, and maintenance of the treatment for patients with IBD.

Related Keywords

Milan , Lombardia , Italy , Fatebenefratelli Sacco , University Of Milan , Drug Administration , Enthera Pharmaceuticals Sandro Ardizzone , Enthera Pharmaceuticals , Sandro Ardizzone , Dig Liver , Inflammatory Bowel Disease , Accessed October , Tumor Necrosis Factor , Anti Tnf , Anti Tnf Therapy , Anti Tumor Necrosis Factor Therapy , Delphi , Consensus , Introduction , Optimization , Maintenance , Ibd , Ulcerative Colitis , Uc , Crohn Disease , Cd , Crohn X27s Disease ,